Showing results (221-230 of 232) with videos related to
Sort By:
Pageof 24
Journal of Hepatology|June 17, 2022
Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapyMan-Fung Yuen, Jeong Heo, Hiromitsu Kumada, et al.Journal of Gastroenterology and Hepatology|January 31, 2018
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in ChinaLai Wei, Qing Xie, Jin Lin Hou, et al.Hepatology International|October 26, 2019
Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific regionTao Chen, Zhongyuan Yang, Ashok Kumar Choudhury, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2019
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 CountriesJin-Lin Hou, Wei Zhao, Changhyeong Lee, et al.Journal of Gastroenterology and Hepatology|April 5, 2017
Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of 'golden window': A prospective studyAshok Choudhury, Manoj Kumar, Barjesh C Sharma, et al.The Lancet. Gastroenterology & Hepatology|December 18, 2018
Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trialLai Wei, Seng Gee Lim, Qing Xie, et al.Journal of Clinical and Translational Hepatology|January 10, 2020
Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis BShan Shan, Hong You, Junqi Niu, et al.Hepatology International|June 26, 2021
Comparative accuracy of prognostic models for short-term mortality in acute-on-chronic liver failure patients: CAP-ACLFNipun Verma, Radha Krishan Dhiman, Virendra Singh, et al.Hepatology International|October 5, 2021
'First week' is the crucial period for deciding living donor liver transplantation in patients with acute-on-chronic liver failureAshok Choudhury, Rajan Vijayaraghavan, Rakhi Maiwall, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 24, 2020
Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failureAjay Duseja, Arka De, Sunil Taneja, et al.Pageof 24